SupplySide Global 2025: Bioiberica and joint health

Amid the bustle of SupplySide Global 2025, one of the world's most important events in the nutraceutical industry, we captured the attention of professionals and specialized media with the announcement of promising scientific results for joint health. Coinciding with Bioiberica's 50th anniversary, our team presented new clinical data on Collavant n2, an undenatured type II collagen that is making significant differences in joint care.

Antonio Vendrell, Bioiberica's marketing and communications director, was responsible for sharing the most recent findings in an interview during the fair with the specialized portal Nutritional Outlook.

With restrained but evident enthusiasm, Vendrell detailed the results of a study that had just been made public: "We are very excited because these results show, through a biomarker, how Collavant n2 is positively effective versus a placebo group."

A biomarker that makes the difference

The core of the news lies in a specific biomarker: CTX-II, a key indicator of cartilage degradation. When this biomarker is present at elevated levels, it signals that there is deterioration of cartilage tissue. The study results were conclusive: in the group that received placebo, a certain amount of this biomarker was detected, while in the group treated with Collavant n2, the levels were significantly lower.

"The difference is close to 40 percentage points," explains Vendrell, adding that "the healthy subjects who used Collavant had this benefit of 40 percentage points of having less CTX-II, which means that Collavant n2 preserves cartilage to a greater extent than if it is not taken."

This figure represents a considerable advance in the field of preventive joint health, especially in a context where population aging and the search for natural solutions to maintain mobility are constantly growing.

Longevity and healthy aging: Bioiberica's commitment

Our booth at SupplySide Global 2025 not only stood out for the presentation of these scientific data, but also for its clear orientation towards one of the most powerful trends of the moment: healthy aging. Vendrell was clear about it: "We see an enormous trend around longevity, healthy aging. If you think of a person who wants to help that favorable evolution, you probably imagine them using a multifunctional product."

Bioiberica's strategy to address this market is articulated around three branded ingredients that cover different needs of the mature consumer:

• Collavant n2: enfocado en la movilidad y salud articular
• Mobilee®: también orientado a la movilidad
• Dermial®: dedicado a la belleza desde dentro

"They are ingredients that can fit very well in a nutraceutical aimed at this type of target," noted the executive, recognizing that the longevity consumer seeks solutions that simultaneously address mobility, beauty, and other essential elements for a full life.

First NutraStrong certification for a collagen

Among the milestones we shared at the fair, the obtaining of the NutraStrong certification for Collavant n2 stands out especially, making it the first collagen to achieve this distinction. This certification, granted by SGS Nutrasource and with the support of the Collagen Stewardship Alliance, represents a seal of transparency and quality that manufacturers and end consumers increasingly value.

"We had the opportunity to share with SGS Nutrasource how we produce and how we collaborate in the development of Collavant n2," explained Vendrell. "For us it is important because it is part of our product proposition: to be transparent, to be clear and to ensure quality in the products we make."

In a market saturated with collagen supplements where not all products meet rigorous quality standards, this certification differentiates Bioiberica and reinforces its commitment to science and traceability.

Bioiberica's 50th anniversary

Our participation in this edition of SupplySide Global takes on special significance when framed in the celebration of our 50th anniversary, with a renewed brand purpose with an ambitious declaration: to make the world a healthier and safer place.

Vendrell explained the philosophy that underpins this purpose: "At Bioiberica we are a life sciences company. We provide science to humans, animals and plants, and we basically see this as providing health solutions to any living being, because those are the three types of living beings we have in this world."

Our holistic approach is especially relevant at a time when the interconnection between human, animal and plant health is increasingly recognized. "Animals eat plants, people eat animals, and then we have health for animals, health for plants, health for people," the executive argued. "We see everything very related, and that's why we approach it as health and safety at the same time."

A clear message from Las Vegas

At the end of the interview, it was clear that we came to SupplySide Global 2025 to consolidate our position as a scientific reference in the nutraceutical sector. The combination of robust clinical evidence, independent quality certifications, and a portfolio strategically aligned with market trends, paints the portrait of a company in which, after five decades of trajectory, we continue to bet on innovation backed by science.

Amid the bustle of one of the industry's busiest events, our message resonated clearly: joint health and healthy aging are achievable goals when science and quality go hand in hand.

And the 40 percentage points of improvement in cartilage preservation are the best proof that we are on the right track.